Triple Negative Breast Cancer News and Research

RSS

Research findings may provide new treatment for prevention of cancer metastasis

Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.

9 Jan 2017

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Researchers are looking at a drug once used to improve blood flow in damaged hearts in thousands of patients as a possible treatment option for triple negative breast cancer (TNBC).

6 Jan 2017

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer--the most aggressive subtype of triple negative breast cancer, into patients in just under four years.

6 Jan 2017

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

Scientists have revealed how cancer cells are able to break free of the physical restraints imposed by their surroundings in order to grow and spread around the body.

5 Jan 2017

Breast cancer patient finds new hope with potentially revolutionary treatment

City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein.

21 Dec 2016

Research findings could offer novel approach for cancer prevention in women with BRCA1 mutations

Women with inherited mutations in the BRCA1 or BRCA2 genes are at substantially higher risk of breast cancer. For these women, effective prevention strategies are their best hope to reduce their breast cancer risk.

16 Dec 2016

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant systemic therapy (NST).

9 Dec 2016

Study reveals men diagnosed with prostate cancer more likely to die of other diseases

Starting in 1993 and ending in 2001, ten academic medical centers in the United States screened 76,685 men and 78,216 women for prostate, lung, colorectal and ovarian cancers.

8 Dec 2016

Researchers developing model to predict breast cancer patient’s response to chemotherapy

University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators are working to predict, before treatment, whether an aggressive type of breast cancer will respond to chemotherapy.

8 Dec 2016

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research.

5 Dec 2016

Blocking key nutrient uptake may be effective way of treating triple negative breast cancer

Cancer rewires the metabolism of tumor cells, converting them into lean, mean, replicating machines.

21 Nov 2016

BUSM researchers discover new pathway and protein involved in metastasis of breast cancer

Researchers have identified a new pathway and with it a protein, BRD4, necessary for breast cancer cells to spread.

15 Nov 2016

Rutgers Cancer Institute researcher receives grant to explore cell pathway in triple-negative breast cancer

Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $200,000 V Scholar Grant from The V Foundation for Cancer Research to explore a cell pathway in triple-negative breast cancer.

4 Nov 2016

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

A team of scientists from the National University of Singapore (NUS) has established novel insights into the relationship between breast cancer tumour intracellular redox environment and the cancer cells' ability to become invasive.

1 Nov 2016

Research findings may lead to new treatment option for ovarian cancer

A new study has identified an effective combination therapy for treating ovarian cancer cells.

31 Oct 2016

Screening for prolactin receptor could help improve TNBC prognosis and treatment

A study conducted at the Research Institute of the McGill University Health Centre suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive treatments

24 Oct 2016

Triple Negative Breast Cancer News and Research

Research findings may provide new treatment for prevention of cancer metastasis

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

Breast cancer patient finds new hope with potentially revolutionary treatment

Research findings could offer novel approach for cancer prevention in women with BRCA1 mutations

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

Study reveals men diagnosed with prostate cancer more likely to die of other diseases

Researchers developing model to predict breast cancer patient’s response to chemotherapy

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Blocking key nutrient uptake may be effective way of treating triple negative breast cancer

BUSM researchers discover new pathway and protein involved in metastasis of breast cancer

Rutgers Cancer Institute researcher receives grant to explore cell pathway in triple-negative breast cancer

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

Research findings may lead to new treatment option for ovarian cancer

Screening for prolactin receptor could help improve TNBC prognosis and treatment

New clinical study to examine novel dietary approach for TNBC

Houston Methodist researcher receives $4 million to create triple negative breast cancer immunotherapy

Researchers aim to discover new treatments for triple-negative breast cancer

Psychological support may be crucial for physical recovery of breast cancer patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News